In the systematic review and meta-analysis by Guhan et al., the risk of developing breast cancer in MGH genetically-enriched breast cancer with the MITF(E318K) mutation was increased, but significance was not reached (OR 2.67; 95 % CI 0.87–7.83; p = 0.111) [27]. The gene discussed is MITF; the disease is breast cancer.